Status:
COMPLETED
Long-Term Assessment of Safety and Physical Function With AMG 108 in RA
Lead Sponsor:
Amgen
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess long-term safety of SC AMG 108 in the treatment of RA
Eligibility Criteria
Inclusion
- Only subjects eligible for and completing 24 weeks of study 20050168 will be permitted to enroll.
Exclusion
- Subjects not eligible for or not completing 24 weeks of study 20050168 will be excluded.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
690 Patients enrolled
Trial Details
Trial ID
NCT00369473
Start Date
September 1 2006
End Date
June 1 2008
Last Update
December 13 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.